個股熱度排行 | 2月8日港股盤前
根據uSMART輿情監測數據,從7日晚間到8日港股盤前時間段,市場關注指數最高的5只股票是阿裏巴巴-SW、中聯重科、君實生物、時代中國控股、碧桂園。
2月8日—港股關注排行TOP5

阿裏巴巴-SW

關注度第一爲阿裏巴巴-SW,該股上個交易日收盤下跌4.49%,報於115.00港元。近5個交易日累計下跌1.63%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
花旗:軟銀或有意出售阿裏巴巴股票
中國概念股週一收盤漲跌互現 電商股普跌阿裏巴巴跌逾6%
中聯重科

關注度第二爲中聯重科,該股上個交易日收盤上漲0.75%,報於5.36港元。近5個交易日累計下跌0.56%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
中聯重科:擬受讓路暢科技29.99%的股份 後續視情況擬要約收購其不低於18.83%的股份
中聯重科擬7.8億元收購路暢科技29.99%股權 或將進一步增持
君實生物

關注度第三爲君實生物,該股上個交易日收盤上漲2.81%,報於45.75港元。近5個交易日累計下跌4.19%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
君實生物:Aurora A 抑制劑 JS112獲得藥物臨牀試驗批準通知書
國泰君安:維持君實生物增持評級
時代中國控股

關注度第四爲時代中國控股,該股上個交易日收盤上漲1.94%,報於3.15港元。近5個交易日累計下跌23.17%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
時代中國控股1月合同銷售額70.88億元
時代中國控股1月合同銷售金額約爲70.88億元
碧桂園

關注度第五爲碧桂園,該股上個交易日收盤上漲0.46%,報於6.49港元。近5個交易日累計下跌2.26%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
碧桂園1月實現歸屬公司股東權益的合同銷售金額約363.6億元
碧桂園1月合同銷售金額約363.6億元
此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。
2月8日—港股輿情轉折預警

君實生物

君實生物輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。
其中較被市場關注的消息有:
君實生物:Aurora A 抑制劑 JS112獲得藥物臨牀試驗批準通知書
國泰君安:維持君實生物增持評級
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.